跳至主要内容
临床试验/ACTRN12618000990224
ACTRN12618000990224已完成未知

A clinical evaluation of ROSA Knee 1.0 Robotic Total Knee Application used in primary total knee arthroplasty - a pilot study to evaluate the ROSA Knee System applications and performance intra-operatively.

Zimmer Biomet Pty Ltd0 个研究点目标入组 64 人开始时间: 2018年6月13日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patient qualifies for a primary total knee arthroplasty based on the investigator’s clinical judgement
  • Independent of study participation, patient is a candidate for commercially available Persona Total Knee or Vanguard Total Knee or NexGen Total Knee arthroplasty

排除标准

  • Patient has active, local infection or previous intra-articular infection in the affected joint
  • Insufficient bone stock on femoral or tibial surfaces
  • Neuropathic arthroplasty
  • Osteomalacia or any metabolic disorder which may impair bone formation
  • Severe instability secondary to the absence of collateral ligament integrity
  • Rheumatoid arthritis accompanied by an ulcer of the skin or history of recurrent breakdown of the skin

研究者

发起方
Zimmer Biomet Pty Ltd

相似试验